Search - tctmd.com

Displaying 101 - 120 of 313

Sort: Relevancy | Date

News Conference News ESC 2022

CV Care Around Noncardiac Surgery: New ESC Guidelines

Michael O'Riordan

September 07, 2022

News Conference News ESC 2022

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Michael O'Riordan

August 31, 2022

News Conference News ESC 2022

Polypill Bests Usual Care in Patients With Recent MI: SECURE

Michael O'Riordan

August 26, 2022

News Opinion Editor's Corner ESC 2022

What’s Going to Be Hot at ESC 2022?

Shelley Wood

August 22, 2022

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Todd Neale

July 20, 2022

News Daily News

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Michael O'Riordan

July 11, 2022

News Daily News

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

L.A. McKeown

June 29, 2022

News

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

Todd Neale

June 17, 2022

News Opinion CV Team Dispatch

June 2022 News Roundup

L.A. McKeown

June 01, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

Michael O'Riordan

April 27, 2022

News Conference News ACC 2022

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

Michael O'Riordan

April 13, 2022

News Conference News ACC 2022

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

Todd Neale

April 02, 2022

News Opinion CV Team Dispatch

April 2022 News Roundup

L.A. McKeown

April 01, 2022

News Daily News

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Michael O'Riordan

March 30, 2022

News Daily News

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Michael O'Riordan

March 01, 2022

News Daily News

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

Michael O'Riordan

January 25, 2022

News Features

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

Michael O'Riordan

December 23, 2021

News Daily News

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

Michael O'Riordan

December 22, 2021

News Daily News

British Medical Groups Express Concern About Inclisiran Rollout

Michael O'Riordan

December 14, 2021

Advertisement

CV Care Around Noncardiac Surgery: New ESC Guidelines

Earlier Evolocumab Cut CVD, CV Mortality Over Longer Term: FOURIER-OLE

Polypill Bests Usual Care in Patients With Recent MI: SECURE

What’s Going to Be Hot at ESC 2022?

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

LVEF Analysis Digs Anew Into Revascularization Benefits in Ischemic CAD

Rivaroxaban Offers VTE Protection in Postprocedure PAD Patients

‘Less Is More’ for Patients With AF and Stable CAD: AFIRE Analysis

June 2022 News Roundup

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

PCI and CABG Are Complementary Options for Left Main CAD, Say Experts

No Difference in 1-Year QoL Between FFR-Guided PCI and CABG: FAME-3

POISE-3: Tranexamic Acid Stems Bleeding During Noncardiac Surgery

April 2022 News Roundup

Clopidogrel Superior to ‘Divine’ Aspirin Monotherapy in Secondary Prevention

Skipping Low-Value Cardiovascular Care Could Save Billions: AHA

Optimal Medical Therapy for Stable Angina: Which Drugs? How Long?

FFR’s Future: Negative Trials Spur Debate Over Technology’s Role

FDA Approves Inclisiran, a Twice-Yearly Injection to Lower LDL Levels

British Medical Groups Express Concern About Inclisiran Rollout

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content